304 related articles for article (PubMed ID: 12532424)
41. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis.
Chen S; Akbar SM; Tanimoto K; Ninomiya T; Iuchi H; Michitaka K; Horiike N; Onji M
Cancer Lett; 2000 Jan; 148(1):49-57. PubMed ID: 10680592
[TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.
Nakashima T; Kondoh S; Kitoh H; Ozawa H; Okita S; Harada T; Shiraishi K; Ryozawa S; Okita K
Int J Mol Med; 2003 Jan; 11(1):33-9. PubMed ID: 12469214
[TBL] [Abstract][Full Text] [Related]
43. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
[TBL] [Abstract][Full Text] [Related]
44. Immunophenotypic characterization and distribution of dendritic cells in odontogenic cystic lesions.
Matos FT; Rizo VH; Almeida LY; Tirapelli C; Silva-Sousa YT; Almeida OP; León JE
Oral Dis; 2013 Jan; 19(1):85-91. PubMed ID: 22788684
[TBL] [Abstract][Full Text] [Related]
45. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
46. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
47. Influence of the in situ component in 389 infiltrating ductal breast carcinomas.
Carabias-Meseguer P; Zapardiel I; Cusidó-Gimferrer M; Godoy-Tundidor S; Tresserra-Casas F; Rodriguez-García I; Fábregas-Xauradó R; Xercavins-Montosa J
Breast Cancer; 2013 Jul; 20(3):213-7. PubMed ID: 22271067
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
49. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
50. Clinical relevance of amphiregulin and VEGF in primary breast cancers.
Desruisseau S; Palmari J; Giusti C; Romain S; Martin PM; Berthois Y
Int J Cancer; 2004 Sep; 111(5):733-40. PubMed ID: 15252843
[TBL] [Abstract][Full Text] [Related]
51. [Tumor angiogenesis in node-negative breast carcinoma].
Li HJ; Jing J; Zhao YB; Zhu JQ; Zhang SY; Shi ZD
Ai Zheng; 2002 Jan; 21(1):75-8. PubMed ID: 12500403
[TBL] [Abstract][Full Text] [Related]
52. Endometrial dendritic cell populations during the normal menstrual cycle.
Schulke L; Manconi F; Markham R; Fraser IS
Hum Reprod; 2008 Jul; 23(7):1574-80. PubMed ID: 18285323
[TBL] [Abstract][Full Text] [Related]
53. Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study.
Kim SJ; Shiba E; Ishii H; Inoue T; Taguchi T; Tanji Y; Kimoto Y; Izukura M; Takai S
Anticancer Res; 1997; 17(3C):2319-23. PubMed ID: 9216709
[TBL] [Abstract][Full Text] [Related]
54. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
[TBL] [Abstract][Full Text] [Related]
55. Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.
Molenkamp BG; Vuylsteke RJ; van Leeuwen PA; Meijer S; Vos W; Wijnands PG; Scheper RJ; de Gruijl TD
Am J Pathol; 2005 Nov; 167(5):1301-7. PubMed ID: 16251414
[TBL] [Abstract][Full Text] [Related]
56. Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.
Dai XL; Zhou SL; Qiu J; Liu YF; Hua H
Eur J Gynaecol Oncol; 2012; 33(6):633-9. PubMed ID: 23327061
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
[TBL] [Abstract][Full Text] [Related]
58. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.
Lespagnard L; Gancberg D; Rouas G; Leclercq G; de Saint-Aubain Somerhausen N; Di Leo A; Piccart M; Verhest A; Larsimont D
Int J Cancer; 1999 Jun; 84(3):309-14. PubMed ID: 10371352
[TBL] [Abstract][Full Text] [Related]
59. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules.
McMullen TP; Lai R; Dabbagh L; Wallace TM; de Gara CJ
Clin Exp Immunol; 2010 Jul; 161(1):81-8. PubMed ID: 20408858
[TBL] [Abstract][Full Text] [Related]
60. Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.
Têtu B; Brisson J; Lapointe H; Wang CS; Bernard P; Blanchette C
Breast Cancer Res Treat; 1999 May; 55(2):137-47. PubMed ID: 10481941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
